Pharmaceuticals and Healthcare

Human Insulin Market by Product (Traditional Human Insulin, and Analogue Insulin), by Diabetes Type (Type1 Diabetes, and Type 2 Diabetes), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2023 to 2032

Publish Date: Jun, 2023 | Report ID: 420380 | Price: $4700

The Human Insulin market is expected to grow from USD 18.6 billion in 2022 to USD 39.4 Billion by 2032, at a CAGR of 7.80% during the forecast period 2023-2032. Human insulin is the term used to refer to laboratory-gr...

Know More

Drug Addiction Treatment Market by Addiction (Vaping, Alcohol, and Tobacco/Nicotine), by Treatment (Rehabilitation Programs, Counselling and Behavioural, and Detoxification), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2023 to 2032

Publish Date: Jun, 2023 | Report ID: 420377 | Price: $4700

The Drug Addiction Treatment market is expected to grow from USD 7.3 billion in 2022 to USD 13.3 Billion by 2032, at a CAGR of 6.20% during the forecast period 2023-2032. Drug addiction needs a comprehensive evaluatio...

Know More

CBD Product Market by Source Type (Marijuana, and Hemp), by Distribution Channel (B2C, and B2B), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2023 to 2032

Publish Date: Jun, 2023 | Report ID: 420375 | Price: $4700

The CBD Product market is expected to grow from USD 5.9 billion in 2022 to USD 28.11 Billion by 2032, at a CAGR of 16.90% during the forecast period 2023-2032. CBD, or cannabidiol, is the second most dominant active i...

Know More

Acute Repetitive Seizures Market by Product Type (NRL-1, AZ-002, Diastat Rectal Gel, USL-261, and Others), by End-use (Biotechnology, Healthcare and Pharmaceuticals, and Others), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2023 to 2032

Publish Date: Jun, 2023 | Report ID: 420372 | Price: $4700

The Acute Repetitive Seizures market is expected to grow from USD 0.65 billion in 2022 to USD 28.2 billion by 2032, at a CAGR of 45.80% during the forecast period 2023-2032. Acute repetitive seizures, also named seizu...

Know More

Paclitaxel Injection Market By Indication (Breast Cancer, AIDS Related Kaposi’s Sarcoma, Cervical Cancer, Pancreatic Cancer, Ovarian Cancer, Stomach Cancer, Lungs Cancer, Esophageal Cancer, Prostate Cancer, Testicular Cancer, and Others), By End-User (Hospitals, Clinics, and Cancer Research Institute), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2023 to 2032

Publish Date: Jun, 2023 | Report ID: 420366 | Price: $4700

The paclitaxel injection market is expected to grow from USD 6.1 billion in 2022 to USD 22.6 billion by 2032, at a CAGR of 14% during the forecast period 2023-2032. Paclitaxel is a cancer treatment medication that bel...

Know More

Browse Reports

All Consumer Goods Heavy Industry Medical Devices Technology Automotive Chemicals and Materials Energy & Power Food & Beverages Manufacturing & Construction Pharmaceuticals and Healthcare Telecommunications and Wireless Public Sector Electronics Aerospace & Defence Business Services Agriculture Instrument Machinery & Equipment Entertainment Animal Commodities Life Science